Log in to save to my catalogue

Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia en...

Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia en...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a15d61b7a0c4d80b36bc24f394b913a

Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series

About this item

Full title

Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series

Publisher

Germany: John Wiley & Sons, Inc

Journal title

Journal of cachexia, sarcopenia and muscle, 2024-06, Vol.15 (3), p.794-815

Language

English

Formats

Publication information

Publisher

Germany: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

The use of patient‐reported outcomes (PROMs) of quality of life (QOL) is common in cachexia trials. Patients' self‐report on health, functioning, wellbeing, and perceptions of care, represent important measures of efficacy. This review describes the frequency, variety, and reporting of QOL endpoints used in cancer cachexia clinical trials. Electron...

Alternative Titles

Full title

Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7a15d61b7a0c4d80b36bc24f394b913a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a15d61b7a0c4d80b36bc24f394b913a

Other Identifiers

ISSN

2190-5991,2190-6009

E-ISSN

2190-6009

DOI

10.1002/jcsm.13453

How to access this item